When the failing, end-stage heart is not end-stage

New England Journal of Medicine

Volumn 355, Issue 18, 2006, Pages 1922-1925

  Renlund, Dale G ^a,b,c   Kfoury, Abdallah G ^a,b  

^a Utah Transplantation Affiliated Hospitals UTAH   (United States)

^b LDS HOSPITAL   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLENBUTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PHOSPHODIESTERASE INHIBITOR;

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL FEATURE; DEVICE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG TOLERABILITY; EDITORIAL; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART HEMODYNAMICS; HEART TRANSPLANTATION; HUMAN; MORBIDITY; MORTALITY; NOMENCLATURE; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SURVIVAL RATE; TERMINAL CARE; TREATMENT OUTCOME; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT;

ADRENERGIC BETA-AGONISTS; CARDIOVASCULAR AGENTS; COMBINED MODALITY THERAPY; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; RECEPTORS, ADRENERGIC, BETA-2;

EID: 33750631145     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe068184     Document Type: Editorial

References (11)

1. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of heart failure): developed in collaboration with the International Society for Heart and Lung Transplantation: endorsed by the Heart Failure Society of America. Circulation 2001;104:2996-3007.
2. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:1825-52.
3. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001;345:1435-43.
4. Shakar SF, Abraham WT, Gilbert EM, et al. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure. J Am Coll Cardiol 1998;31:1336-40.
5. Dipla K, Mattiello JA, Jeevanandam V, Houser SR, Margulies KB. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 1998;97:2316-22.
6. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998;83:1-14.
7. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A 1998;95:8801-5.
8. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-76.
9. Anversa P, Nadal-Ginard B. Myocyte renewal and ventricular remodeling. Nature 2002;415:240-3.
10. Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006;355:1873-84.
11. Klotz S, Foronjy RF, Dickstein ML, et al. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness. Circulation 2005;112:364-74.